Abstract
A procedure for preparing 1-(2-hydroxy-3-[18F]fluoropropyl)-2-nitroimidazole ([18F]fluoromisonidazole, [18F]FMISO) on a commercially available GE TracerLAB Fx F-N synthesis module was developed. The product obtained meets all the requirements of the European Pharmacopoeia (8th ed.) for clinical use. Its decay-corrected radiochemical yield is 59 ± 4% (n = 5).
Similar content being viewed by others
References
Eschmann, S.M., Paulsen, F., Reimold, M., et al., J. Nucl. Med., 2005, vol. 46, no. 2, pp. 253–260.
Spence, A.M., Muzi, M., Swanson, K.R., et al., Clin. Cancer Res., 2008, vol. 14, no. 9, pp. 2623–2630.
Vaupel, P. and Mayer, A., Cancer Metastasis Rev., 2007, vol. 26, no. 2, pp. 225–239.
Antuganov, D.O., Ryzhkova, D.V., and Zykov, M.P., Radiochemistry, 2015, vol. 57, no. 6, pp. 621–631.
Blom, E. and Koziorowski, J., J. Radioanal. Nucl. Chem., 2014, vol. 229, no. 1, pp. 265–270.
European Pharmacopoeia, Strasbourg: Council of Europe, 2013, 8th ed., vol. 1, pp. 1058–1060.
OFS (General Pharmacopoeia Monograph) 1.1.0008.15: Residual Organic Solvents.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.O. Antuganov, D.V. Ryzhkova, T.A. Zykova, V.V. Timofeev, Yu.O. Antuganova, K.Yu. Timofeeva, O.P. Samburov, M.P. Zykov, 2018, published in Radiokhimiya, 2018, Vol. 60, No. 1, pp. 44–48.
Rights and permissions
About this article
Cite this article
Antuganov, D.O., Ryzhkova, D.V., Zykova, T.A. et al. Modification of Automatic Synthesis of [18F]Fluoromisonidazole on a GE TracerLAB Fx F-N Synthesis Module. Radiochemistry 60, 45–50 (2018). https://doi.org/10.1134/S1066362218010083
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362218010083